BMY vs GNSS · P/E 17, rev $24.46B vs rev $39.9M
Bristol-Myers Squibb Company (BMY) versus Genasys Inc (GNSS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Genasys Inc (GNSS) is a scientific & technical instruments company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported GNSS revenue for 2026-06-30 was $39.9M. Net income was -$4.8M. Revenue was up 22.4% from 2026-03-31 to 2026-06-30. GNSS currently screens at market cap $76.3M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. GNSS currently screens at market cap $76.3M.
Not investment advice. Open the BMY and GNSS stock pages for the full models.
Not investment advice.